12 Analysts Assess 10x Genomics: What You Need To Know
12 Analysts Assess 10x Genomics: What You Need To Know
12位分析師評估10x genomics：你需要知道什麼
In the preceding three months, 12 analysts have released ratings for 10x Genomics (NASDAQ:TXG), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，有12名分析師對10x genomics（納斯達克：TXG）發佈了評級，提出了從看好到看淡的各種觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他們最近的評級，展示了過去30天內的情緒演變並與之前的幾個月進行了比較。
Analysts have set 12-month price targets for 10x Genomics, revealing an average target of $33.0, a high estimate of $55.00, and a low estimate of $16.00. Observing a downward trend, the current average is 33.02% lower than the prior average price target of $49.27.
分析師已爲10x genomics設定了12個月的價值目標，顯示平均目標爲33.0美元，最高估計爲55.00美元，最低估計爲16.00美元。當前平均值比之前的平均價值目標49.27美元低了33.02％，呈現下降趨勢。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細剖析
In examining recent analyst actions, we gain insights...
通過審查最近的分...
登入免費觀看全文
登入/註冊